CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The Facer is an innovative, fully-autonomous cell culture platform that produces large quantities of high-quality cells for cell therapy applications. It eliminates the need for human intervention, significantly reducing costs and enabling scalable production, thus addressing the growing demand for affordable cell ther…
Cell therapy has shown promising results for treating and curing a large range of diseases, from cancer to diabetes.
The principles of cell therapy are easy to describe: cells (possibly modified) are injected into patients.
Cell therapy is now a reality in Europe: in August 2018 the first two treatments for patients with blood cancer were approved; more of them are about to successfully conclude the approval path.
What hinders the large-scale uptake of cell therapy is its costs: culturing enough…
AGLARIS LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
